Search results
Is ORNAX a Strong Bond Fund Right Now?
Zacks via Yahoo Finance· 4 days agoIf investors are looking at the Muni - Bonds fund category, Oppenheimer Rochester High Yield Municipals A (ORNAX) could be a potential option. ORNAX has...
Everything we know about 'A Quiet Place: Day One'
Space via Yahoo News· 2 days agoLupita Nyong'o (Black Panther: Wakanda Forever) stars as Sam and is joined by Joseph Quinn (Stranger Things) as Eric, Alex Wolff (Oppenheimer) as Reuben,...
ESSA Pharma’s (EPIX) Outperform Rating Reiterated at Oppenheimer
ETF DAILY NEWS· 2 days agoOppenheimer reiterated their outperform rating on shares of ESSA Pharma (NASDAQ:EPIX – Free Report) (TSE:EPI) in a research report sent to investors on Thursday morning, Benzinga ...
Oppenheimer Trims Workday (NASDAQ:WDAY) Target Price to $320.00
ETF DAILY NEWS· 3 days agoWorkday (NASDAQ:WDAY – Free Report) had its price objective reduced by Oppenheimer from $350.00 to $320.00 in a research report report published on Wednesday morning, Benzinga ...
NVIDIA Q1 Earnings Preview: Analysts Anticipate Strong Results, Top AI Stock — 'Best Secular Idea In...
Benzinga· 5 hours agoSemiconductor giant NVIDIA Corporation NVDA will report first-quarter financial results after market...
Amazon's Massive Book Sale Ends Tonight: Save Up to 80% on Bestsellers
Entertainment Tonight· 4 hours agoReading a new book beachside, poolside or during a summer trip is one of the best ways to soak up...
Amazon's Upfront Presentation Highlights Strong Push into Movies and Sports Advertising: Analyst -...
Benzinga· 5 days agoOppenheimer analyst Jason Helfstein reiterated an Outperform rating on Amazon.Com Inc AMZN with a...
Wall Street strategists rush to revise their S&P 500 targets as stocks hit fresh records. Here’s...
Market Watch· 7 hours agoAt 5,600 points, BMO’s new target appears to be the most bullish forecast among Wall Street’s...
Here's what to watch on National Streaming Day
USA Today· 13 hours agoNowadays, there are so many streaming services available that it can be hard to know which one to go with. The days of all your favorite shows being on...
Acrivon Therapeutics maintains Outperform rating, $21 target By Investing.com
Investing.com· 6 days agoOn Tuesday, Oppenheimer maintained its positive stance on Acrivon Therapeutics Inc (NASDAQ: ACRV),...